Prof.Dr.med. ID: 63635

Victor-Felix Mautner

graph of relations

Publications

  1. 2010
  2. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2

    Mautner, V-F., Nguyen, R., Kutta, H., Fuensterer, C., Bokemeyer, C., Hagel, C., Friedrich, R. E. & Panse, J., 01.01.2010, In: NEURO-ONCOLOGY. 12, 1, p. 14-8 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.

    Thomas, L., Kluwe, L., Chuzhanova, N., Mautner, V. F. & Upadhyaya, M., 2010, In: NEUROGENETICS. 11, 4, p. 391-400 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. A novel third type of recurrent NF1 microdeletion mediated by nonallelic homologous recombination between LRRC37B-containing low-copy repeats in 17q11.2.

    Bengesser, K., Cooper, D. N., Steinmann, K., Kluwe, L., Chuzhanova, N. A., Wimmer, K., Tatagiba, M., Tinschert, S., Mautner, V. F. & Kehrer-Sawatzki, H., 2010, In: HUM MUTAT. 31, 6, p. 742-751 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.

    Mautner, V. F., Kluwe, L., Friedrich, R., Roehl, A. C., Bammert, S., Högel, J., Spöri, H., Cooper, D. N. & Kehrer-Sawatzki, H., 2010, In: J MED GENET. 47, 9, p. 623-630 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.

    Stewart, D. R., Sloan, J. L., Yao, L., Mannes, A. J., Armin, M., Lee, C-C. R., Sciot, R., Luc, D. S., Mautner, V. F. & Legius, E., 2010, In: J MED GENET. 47, 8, p. 525-532 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Extended runs of homozygosity at 17q11.2: an association with type-2 NF1 deletions?

    Roehl, A. C., Cooper, D. N., Kluwe, L., Helbrich, A., Wimmer, K., Högel, J., Mautner, V. F. & Kehrer-Sawatzki, H., 2010, In: HUM MUTAT. 31, 3, p. 325-334 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.

    Hummel, T. R., Jessen, W. J., Miller, S. J., Kluwe, L., Mautner, V. F., Wallace, M. R., Lázaro, C., Page, G. P., Worley, P. F., Aronow, B. J., Schorry, E. K. & Ratner, N., 2010, In: CLIN CANCER RES. 16, 20, p. 5048-5057 20.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1.

    Seitz, S., Schnabel, C., Busse, B., Schmidt, H., Beil, F. T., Friedrich, R., Schinke, T., Mautner, V. F. & Amling, M., 2010, In: OSTEOPOROSIS INT. 21, 1, p. 119-127 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model.

    Demestre, M., Herzberg, J., Holtkamp, N., Hagel, C., Reuss, D., Friedrich, R. E., Kluwe, L., Andreas, V. D., Mautner, V. F. & Kurtz, A., 2010, In: J NEURO-ONCOL. 98, 1, p. 11-19 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions.

    Roehl, A. C., Vogt, J., Mussotter, T., Zickler, A. N., Spöti, H., Högel, J., Chuzhanova, N. A., Wimmer, K., Kluwe, L., Mautner, V. F., Cooper, D. N. & Kehrer-Sawatzki, H., 2010, In: HUM MUTAT. 31, 10, p. 1163-1173 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Large intragenic deletions of the NF2 gene: breakpoints and associated phenotypes.

    Abo-Dalo, B., Kutsche, K., Mautner, V. F. & Kluwe, L., 2010, In: GENE CHROMOSOME CANC. 49, 2, p. 171-175 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Monozygotic twins with neurofibromatosis type 1 (NF1) display differences in methylation of NF1 gene promoter elements, 5' untranslated region, exon and intron 1.

    Harder, A., Titze, S., Herbst, L., Harder, T., Guse, K., Tinschert, S., Kaufmann, D., Rosenbaum, T., Mautner, V. F., Windt, E., Wahlländer-Danek, U., Wimmer, K., Mundlos, S. & Peters, H., 2010, In: TWIN RES HUM GENET. 13, 6, p. 582-594 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Neuro-kardio-fazio-kutane Syndrome: Überlappende Phänotypen mit gemeinsamem molekularem Signalweg interdisziplinäres Betreuungskonzept

    Mautner, V. F., Nguyen, R., Bernhardt, A., Von Kodolitsch, Y., Zenker, M. & Kutsche, K., 2010, In: MED GENET-BERLIN. 1, p. 10-19

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers.

    Kissil, J. L., Blakeley, J. O., Ferner, R. E., Huson, S. M., Kalamarides, M., Mautner, V. F., McCormick, F., Morrison, H., Packer, R., Ramesh, V., Ratner, N., Rauen, K. A., Stevenson, D. A., Hunter-Schaedle, K. & North, K., 2010, In: AM J MED GENET A. 152, 2, p. 269-283 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. 2009
  17. Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice.

    Messerli, S. M., Ahn, M-R., Kunimasa, K., Yanagihara, M., Tatefuji, T., Hashimoto, K., Mautner, V. F., Uto, Y., Hori, H., Kumazawa, S., Kaji, K., Ohta, T. & Maruta, H., 2009, In: PHYTOTHER RES. 23, 3, p. 423-427 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).

    Tucker, T., Schnabel, C., Hartmann, M., Friedrich, R., Frieling, I., Kruse, H-P., Mautner, V. F. & Friedman, J. M., 2009, In: J MED GENET. 46, 4, p. 259-265 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice.

    Demestre, M., Messerli, S. M., Celli, N., Shahhossini, M., Kluwe, L., Mautner, V. F. & Maruta, H., 2009, In: PHYTOTHER RES. 23, 2, p. 226-230 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.

    Mantripragada, K. K., Ståhl, D., Díaz, T., Patridge, C., Menzel, U., Andersson, R., Kluwe, L., Kluwe, L., Mautner, V. F., Mautner, V., Dumanski, J. P. & Upadhyaya, M., 2009, In: GENE CHROMOSOME CANC. 48, 10, p. 897-907 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association.

    Brems, H., Park, C., Maertens, O., Pemov, A., Messiaen, L., Messia, L., Upadhyaya, M., Claes, K., Beert, E., Peeters, K., Mautner, V. F., Sloan, J. L., Yao, L., Lee, C-C. R., Sciot, R., Luc, D. S., Legius, E. & Stewart, D. R., 2009, In: CANCER RES. 69, 18, p. 7393-7401 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.

    Tucker, T., Friedman, J. M., Friedrich, R., Wenzel, R., Fünsterer, C. & Mautner, V. F., 2009, In: J MED GENET. 46, 2, p. 81-85 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.

    Steinmann, K., Kluwe, L., Friedrich, R., Mautner, V. F., Cooper, D. N. & Kehrer-Sawatzki, H., 2009, In: J INVEST DERMATOL. 129, 3, p. 615-621 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Neurokutane Erkrankungen

    PANTELIADIS, CP., Hagel, C., Mautner, V. F., Friedrich, R. & ROSENBAUM, T., 2009, Neuropädiatrie - Evidenzbasierte Therapie. Elsevier, p. 67-87 21 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesResearchpeer-review

  25. Ral overactivation in malignant peripheral nerve sheath tumors.

    Vidya, B., Yamoutpoor, F., Pan, W., Dudek, A. Z., Esfandyari, T., Piedra, M., Babovick-Vuksanovic, D., Woo, R. A., Mautner, V. F., Kluwe, L., Vries, D., George, H., Thomas, S. L., Kurtz, A., Parada, L. F. & Farassati, F., 2009, In: MOL CELL BIOL. 29, 14, p. 3964-3974 14.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

    Upadhyaya, M., Spurlock, G., Kluwe, L., Chuzhanova, N., Bennett, E., Thomas, N., Guha, A. & Mautner, V. F., 2009, In: NEUROGENETICS. 10, 3, p. 251-263 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.

    Cai, W., Kassarjian, A., Bredella, M. A., Harris, G. J., Yoshida, H., Mautner, V. F., Wenzel, R. & Plotkin, S. R., 2009, In: RADIOLOGY. 250, 3, p. 665-673 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2008
  29. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.

    Kehrer-Sawatzki, H., Schmid, E., Fünsterer, C., Kluwe, L. & Mautner, V. F., 2008, In: AM J MED GENET A. 146, 6, p. 691-699 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.

    Mautner, V. F., Asuagbor, F. A., Dombi, E., Fünsterer, C., Kluwe, L., Wenzel, R., Widemann, B. C. & Friedman, J. M., 2008, In: NEURO-ONCOLOGY. 10, 4, p. 593-598 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions.

    Steinmann, K., Kluwe, L., Cooper, D. N., Brems, H., Thomas, D. R., Legius, E., Mautner, V. F. & Kehrer-Sawatzki, H., 2008, In: EUR J HUM GENET. 16, 5, p. 572-580 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.

    Feucht, M., Kluwe, L., Mautner, V. F. & Richard, G., 2008, In: ARCH OPHTHALMOL-CHIC. 126, 10, p. 1376-1380 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy.

    Holtkamp, N., Malzer, E., Zietsch, J., Okuducu, A. F., Mucha, J., Mawrin, C., Mautner, V. F., Schildhaus, H-U. & von Deimling, A., 2008, In: NEURO-ONCOLOGY. 10, 6, p. 946-957 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Germline and somatic NF1 gene mutations in plexiform neurofibromas.

    Upadhyaya, M., Spurlock, G., Monem, B., Thomas, N., Friedrich, R., Kluwe, L. & Mautner, V. F., 2008, In: HUM MUTAT. 29, 8, p. 103-111 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs).

    Upadhyaya, M., Kluwe, L., Spurlock, G., Monem, B., Majounie, E., Mantripragada, K., Ruggieri, M., Chuzhanova, N., Evans, D. G., Ferner, R., Thomas, N., Guha, A. & Mautner, V. F., 2008, In: HUM MUTAT. 29, 1, p. 74-82 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. High-resolution DNA copy number profiling of malignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization.

    Mantripragada, K. K., Spurlock, G., Kluwe, L., Chuzhanova, N., Ferner, R. E., Frayling, I. M., Dumanski, J. P., Guha, A., Mautner, V. F. & Upadhyaya, M., 2008, In: CLIN CANCER RES. 14, 4, p. 1015-1024 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Neurofibromatosis 2 leads to higher incidence of strabismological and neuro-ophthalmological disorders.

    Feucht, M., Griffiths, B., Niemüller, I., Haase, W., Richard, G. & Mautner, V. F., 2008, In: ACTA OPHTHALMOL. 86, 8, p. 882-886 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1.

    Buchert, R., Von Borczyskowski, D., Wilke, F., Gronowsky, M., Friedrich, R., Brenner, W., Mester, J., Clausen, M. & Mautner, V. F., 2008, In: NUCL MED COMMUN. 29, 1, p. 17-26 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type 1 individuals.

    Mantripragada, K. K., Caley, M., Stephens, P., Jones, C. J., Kluwe, L., Guha, A., Mautner, V. F. & Upadhyaya, M., 2008, In: GENE CHROMOSOME CANC. 47, 3, p. 238-246 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. 2007
  41. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.

    Mautner, V. F., Brenner, W., Fünsterer, C., Hagel, C., Gawad, K. A. & Friedrich, R., 2007, In: ANTICANCER RES. 27, 4, p. 1819-1822 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Early primary tooth eruption in neurofibromatosis 1 individuals.

    Lammert, M., Friedrich, R. E., Friedman, J. M., Mautner, V. F. & Tucker, T., 2007, In: EUR J ORAL SCI. 115, 5, p. 425-426 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.

    Bausch, B., Borozdin, W., Mautner, V. F., Hoffmann, M. M., Boehm, D., Robledo, M., Cascon, A., Harenberg, T., Schiavi, F., Pawlu, C., Peczkowska, M., Letizia, C., Calvieri, S., Arnaldi, G., Klingenberg-Noftz, R. D., Reisch, N., Fassina, A., Brunaud, L., Walter, M. A., Mannelli, M., MacGregor, G., Palazzo, F. F., Barontini, M., Walz, M. K., Kremens, B., Brabant, G., Pfäffle, R., Koschker, A-C., Lohoefner, F., Mohaupt, M., Gimm, O., Jarzab, B., McWhinney, S. R., Opocher, G., Januszewicz, A., Kohlhase, J., Eng, C. & Neumann, H. P. H., 2007, In: J CLIN ENDOCR METAB. 92, 7, p. 2784-2792 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

    Hagel, C., Zils, U., Peiper, M., Kluwe, L., Gotthard, S., Friedrich, R., Zurakowski, D., von Deimling, A. & Mautner, V. F., 2007, In: J NEURO-ONCOL. 82, 2, p. 187-192 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Loss of heterozygosity in tumor cells of a recurrent mandibular giant cell granuloma in neurofibromatosis type 1.

    Friedrich, R., Mautner, V. F. & Scheuer, H. A., 2007, In: ANTICANCER RES. 27, 4, p. 2079-2083 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.

    Friedrich, R., Hartmann, M. & Mautner, V. F., 2007, In: ANTICANCER RES. 27, 4, p. 1957-1960 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.

    Holtkamp, N., Atallah, I., Okuducu, A-F., Mucha, J., Hartmann, C., Mautner, V. F., Friedrich, R., Mawrin, C. & von Deimling, A., 2007, In: NEOPLASIA. 9, 8, p. 671-677 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Neurofibromatosis 2 leads to choroidal hyperfluorescence in fluorescein angiography.

    Feucht, M., Richard, G. & Mautner, V. F., 2007, In: GRAEF ARCH CLIN EXP. 245, 7, p. 949-953 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

    Steinmann, K., Cooper, D. N., Kluwe, L., Chuzhanova, N. A., Senger, C., Serra, E., Lazaro, C., Gilaberte, M., Wimmer, K., Mautner, V. F. & Kehrer-Sawatzki, H., 2007, In: AM J HUM GENET. 81, 6, p. 1201-1220 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. 2006
  51. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues.

    Miller, S. J., Rangwala, F., Williams, J., Ackerman, P., Kong, S., Jegga, A. G., Kaiser, S., Aronow, B. J., Frahm, S., Kluwe, L., Mautner, V. F., Upadhyaya, M., Muir, D., Wallace, M., Hagen, J., Quelle, D. E., Watson, M. A., Perry, A., Gutmann, D. H. & Ratner, N., 2006, In: CANCER RES. 66, 5, p. 2584-2591 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.

    Mautner, V. F., Hartmann, M., Kluwe, L., Friedrich, R. & Fünsterer, C., 2006, In: NEURORADIOLOGY. 48, 3, p. 160-165 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.

    Holtkamp, N., Okuducu, A. F., Mucha, J., Afanasieva, A., Hartmann, C., Atallah, I., Estevez-Schwarz, L., Mawrin, C., Friedrich, R., Mautner, V. F. & von Deimling, A., 2006, In: CARCINOGENESIS. 27, 3, p. 664-671 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.

    Brenner, W., Friedrich, R., Gawad, K. A., Hagel, C., von Deimling, A., de Wit, M., Buchert, R., Clausen, M. & Mautner, V. F., 2006, In: EUR J NUCL MED MOL I. 33, 4, p. 428-432 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice.

    Hirokawa, Y., Nheu, T., Grimm, K., Mautner, V. F., Maeda, S., Yoshida, M., Komiyama, K. & Maruta, H., 2006, In: CANCER BIOL THER. 5, 3, p. 305-309 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review